Mark G Kris Selected Research

Mark G Kris Research Topics

Disease

146	Neoplasms (Cancer) 12/2023 - 02/2002
116	Lung Neoplasms (Lung Cancer) 12/2023 - 03/2003
77	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 02/2001
63	Adenocarcinoma of Lung 01/2023 - 01/2005
15	Adenocarcinoma 01/2019 - 03/2004
14	Disease Progression 01/2023 - 05/2005
14	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2002
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018 - 02/2003
11	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2002
9	Nausea 01/2018 - 10/2002
8	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2002
8	Vomiting 10/2017 - 10/2002
7	Fatigue 01/2018 - 05/2005
7	Carcinoma (Carcinomatosis) 06/2014 - 07/2002
7	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 05/2011 - 11/2004
5	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 02/2007
5	Stomatitis 08/2007 - 06/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 05/2004
4	Edema (Dropsy) 01/2016 - 06/2003
3	Hypersensitivity (Allergy) 01/2021 - 02/2008
3	Carcinogenesis 01/2021 - 04/2004
3	Mesothelioma 01/2020 - 09/2003
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019 - 05/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2003
3	Thrombocytopenia (Thrombopenia) 10/2018 - 03/2011
3	Neutropenia 10/2018 - 02/2007
3	Exanthema (Rash) 01/2018 - 09/2005
3	Neuroblastoma 02/2015 - 02/2010
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2012 - 05/2007
2	Hemorrhage 01/2022 - 12/2010
2	Malignant Mesothelioma 01/2020 - 04/2007
2	Diarrhea 01/2018 - 09/2005

Drug/Important Bio-Agent (IBA)

65	ErbB Receptors (EGF Receptor)IBA 04/2023 - 06/2003
53	Tyrosine Kinase InhibitorsIBA 12/2023 - 02/2003
41	Gefitinib (Iressa)FDA Link 12/2014 - 06/2003
36	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2005
17	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2010
14	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2002
13	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2007
13	Docetaxel (Taxotere)FDA Link 04/2016 - 02/2001
11	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 02/2001
11	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 06/2003
11	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2015 - 10/2003
9	osimertinibIBA 04/2023 - 01/2018
9	Carboplatin (JM8)FDA LinkGeneric 12/2021 - 06/2003
9	human ERBB2 proteinIBA 12/2019 - 02/2012
8	Phosphotransferases (Kinase)IBA 01/2021 - 01/2005
7	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2018
7	Pemetrexed (MTA)FDA Link 10/2022 - 10/2005
6	PlatinumIBA 11/2023 - 02/2007
6	AfatinibIBA 01/2021 - 10/2012
5	cabozantinibIBA 09/2023 - 06/2013
5	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2010
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 07/2012
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020 - 01/2016
5	Bevacizumab (Avastin)FDA Link 01/2020 - 12/2010
5	AntiemeticsIBA 01/2020 - 10/2002
5	Anaplastic Lymphoma KinaseIBA 03/2016 - 02/2012
4	atezolizumabIBA 12/2023 - 10/2022
4	CrizotinibIBA 09/2023 - 01/2016
4	Gemcitabine FDA Link 01/2020 - 06/2003
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 02/2005
4	Messenger RNA (mRNA)IBA 01/2019 - 05/2004
4	EmeticsIBA 10/2017 - 02/2005
4	Vinorelbine (Navelbine)FDA LinkGeneric 04/2016 - 02/2003
4	10-propargyl-10-deazaaminopterin FDA Link 11/2011 - 05/2006
3	dacomitinibIBA 01/2023 - 12/2014
3	durvalumabIBA 01/2021 - 01/2020
3	Albumin-Bound Paclitaxel FDA Link 01/2020 - 02/2008
3	Cytotoxins (Cytolysins)IBA 01/2020 - 09/2003
3	Temozolomide (Temodar)FDA LinkGeneric 10/2018 - 02/2012
3	Codon (Codons)IBA 03/2015 - 09/2008
3	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2012 - 02/2004
3	Folic Acid AntagonistsIBA 11/2011 - 06/2003
3	Everolimus FDA Link 10/2010 - 08/2007
2	B7-H1 AntigenIBA 11/2023 - 01/2018
2	selpercatinibIBA 09/2023 - 01/2019
2	Protons (Proton)IBA 11/2022 - 01/2021
2	Circulating Tumor DNAIBA 11/2022 - 06/2019
2	trametinibIBA 01/2022 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2021
2	ParaffinIBA 10/2020 - 01/2011
2	Formaldehyde (Formol)FDA Link 10/2020 - 01/2011
2	cyclo(Arg-Pro) (CI 4)IBA 01/2020 - 05/2011
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2018
2	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2018 - 01/2016
2	AnthracyclinesIBA 10/2017 - 02/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2017 - 02/2016

Therapy/Procedure

85	Therapeutics 11/2023 - 10/2003
58	Drug Therapy (Chemotherapy) 11/2023 - 02/2001
17	Radiotherapy 01/2023 - 07/2002
11	Adjuvant Chemotherapy 04/2023 - 07/2007
8	Neoadjuvant Therapy 10/2023 - 09/2012
7	Immunotherapy 01/2021 - 09/2004
5	Aftercare (After-Treatment) 01/2021 - 03/2008
3	Precision Medicine 11/2014 - 01/2007
2	Craniospinal Irradiation 11/2022 - 01/2021
2	Metastasectomy 01/2019 - 03/2013
2	Retreatment 01/2018 - 10/2011